vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and NICOLET BANKSHARES INC (NIC). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $104.0M, roughly 1.2× NICOLET BANKSHARES INC). NICOLET BANKSHARES INC runs the higher net margin — 38.8% vs 4.2%, a 34.6% gap on every dollar of revenue. On growth, NICOLET BANKSHARES INC posted the faster year-over-year revenue change (12.5% vs -1.4%). NICOLET BANKSHARES INC produced more free cash flow last quarter ($149.4M vs $517.0K). Over the past eight quarters, NICOLET BANKSHARES INC's revenue compounded faster (12.5% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.

CLB vs NIC — Head-to-Head

Bigger by revenue
CLB
CLB
1.2× larger
CLB
$121.8M
$104.0M
NIC
Growing faster (revenue YoY)
NIC
NIC
+14.0% gap
NIC
12.5%
-1.4%
CLB
Higher net margin
NIC
NIC
34.6% more per $
NIC
38.8%
4.2%
CLB
More free cash flow
NIC
NIC
$148.9M more FCF
NIC
$149.4M
$517.0K
CLB
Faster 2-yr revenue CAGR
NIC
NIC
Annualised
NIC
12.5%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
NIC
NIC
Revenue
$121.8M
$104.0M
Net Profit
$5.1M
$40.3M
Gross Margin
Operating Margin
1.5%
48.3%
Net Margin
4.2%
38.8%
Revenue YoY
-1.4%
12.5%
Net Profit YoY
16.9%
EPS (diluted)
$0.11
$2.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
NIC
NIC
Q1 26
$121.8M
Q4 25
$138.3M
$104.0M
Q3 25
$134.5M
$102.9M
Q2 25
$130.2M
$95.7M
Q1 25
$123.6M
$89.4M
Q4 24
$129.2M
$92.4M
Q3 24
$134.4M
$90.7M
Q2 24
$130.6M
$85.0M
Net Profit
CLB
CLB
NIC
NIC
Q1 26
$5.1M
Q4 25
$4.9M
$40.3M
Q3 25
$14.2M
$41.7M
Q2 25
$10.6M
$36.0M
Q1 25
$-154.0K
$32.6M
Q4 24
$7.4M
$34.5M
Q3 24
$11.7M
$32.5M
Q2 24
$9.0M
$29.3M
Gross Margin
CLB
CLB
NIC
NIC
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
NIC
NIC
Q1 26
1.5%
Q4 25
11.5%
48.3%
Q3 25
15.6%
50.4%
Q2 25
11.7%
46.8%
Q1 25
3.6%
44.9%
Q4 24
11.0%
46.8%
Q3 24
14.7%
45.0%
Q2 24
12.3%
43.3%
Net Margin
CLB
CLB
NIC
NIC
Q1 26
4.2%
Q4 25
3.6%
38.8%
Q3 25
10.6%
40.6%
Q2 25
8.2%
37.6%
Q1 25
-0.1%
36.4%
Q4 24
5.7%
37.3%
Q3 24
8.7%
35.8%
Q2 24
6.9%
34.5%
EPS (diluted)
CLB
CLB
NIC
NIC
Q1 26
$0.11
Q4 25
$0.11
$2.63
Q3 25
$0.30
$2.73
Q2 25
$0.22
$2.34
Q1 25
$0.00
$2.08
Q4 24
$0.15
$2.21
Q3 24
$0.25
$2.10
Q2 24
$0.19
$1.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
NIC
NIC
Cash + ST InvestmentsLiquidity on hand
$22.8M
Total DebtLower is stronger
$134.9M
Stockholders' EquityBook value
$275.1M
$1.3B
Total Assets
$587.7M
$9.2B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
NIC
NIC
Q1 26
$22.8M
Q4 25
$22.7M
Q3 25
$25.6M
Q2 25
$31.2M
Q1 25
$22.1M
Q4 24
$19.2M
Q3 24
$21.5M
Q2 24
$17.7M
Total Debt
CLB
CLB
NIC
NIC
Q1 26
Q4 25
$110.3M
$134.9M
Q3 25
$114.1M
$134.6M
Q2 25
$124.6M
$134.3M
Q1 25
$124.4M
$156.6M
Q4 24
$126.1M
$161.4M
Q3 24
$139.9M
$161.2M
Q2 24
$147.6M
$162.4M
Stockholders' Equity
CLB
CLB
NIC
NIC
Q1 26
$275.1M
Q4 25
$266.0M
$1.3B
Q3 25
$271.3M
$1.2B
Q2 25
$261.3M
$1.2B
Q1 25
$253.4M
$1.2B
Q4 24
$246.6M
$1.2B
Q3 24
$250.7M
$1.1B
Q2 24
$240.3M
$1.1B
Total Assets
CLB
CLB
NIC
NIC
Q1 26
$587.7M
Q4 25
$584.0M
$9.2B
Q3 25
$591.4M
$9.0B
Q2 25
$602.1M
$8.9B
Q1 25
$591.5M
$9.0B
Q4 24
$585.1M
$8.8B
Q3 24
$600.5M
$8.6B
Q2 24
$597.8M
$8.6B
Debt / Equity
CLB
CLB
NIC
NIC
Q1 26
Q4 25
0.41×
0.11×
Q3 25
0.42×
0.11×
Q2 25
0.48×
0.11×
Q1 25
0.49×
0.13×
Q4 24
0.51×
0.14×
Q3 24
0.56×
0.14×
Q2 24
0.61×
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
NIC
NIC
Operating Cash FlowLast quarter
$4.0M
$153.5M
Free Cash FlowOCF − Capex
$517.0K
$149.4M
FCF MarginFCF / Revenue
0.4%
143.7%
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
0.77×
3.81×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$275.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
NIC
NIC
Q1 26
$4.0M
Q4 25
$7.9M
$153.5M
Q3 25
$8.5M
$45.9M
Q2 25
$13.9M
$38.9M
Q1 25
$6.7M
$41.8M
Q4 24
$20.6M
$133.7M
Q3 24
$13.1M
$39.6M
Q2 24
$17.1M
$37.3M
Free Cash Flow
CLB
CLB
NIC
NIC
Q1 26
$517.0K
Q4 25
$5.0M
$149.4M
Q3 25
$6.5M
$45.9M
Q2 25
$10.4M
$38.4M
Q1 25
$3.9M
$41.3M
Q4 24
$17.4M
$116.8M
Q3 24
$10.4M
$34.7M
Q2 24
$14.3M
$34.4M
FCF Margin
CLB
CLB
NIC
NIC
Q1 26
0.4%
Q4 25
3.6%
143.7%
Q3 25
4.8%
44.6%
Q2 25
8.0%
40.1%
Q1 25
3.1%
46.2%
Q4 24
13.4%
126.4%
Q3 24
7.7%
38.3%
Q2 24
10.9%
40.5%
Capex Intensity
CLB
CLB
NIC
NIC
Q1 26
Q4 25
2.1%
3.9%
Q3 25
1.5%
0.0%
Q2 25
2.7%
0.6%
Q1 25
2.3%
0.5%
Q4 24
2.5%
18.3%
Q3 24
2.0%
5.4%
Q2 24
2.2%
3.5%
Cash Conversion
CLB
CLB
NIC
NIC
Q1 26
0.77×
Q4 25
1.61×
3.81×
Q3 25
0.60×
1.10×
Q2 25
1.31×
1.08×
Q1 25
1.28×
Q4 24
2.78×
3.88×
Q3 24
1.12×
1.22×
Q2 24
1.90×
1.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons